Press release
Zanamivir Market Size, Trends, Growth Analysis, and Forecast | Valuates Reports
Zanamivir Market SizeThe global market for Zanamivir was estimated to be worth US$ 10 million in 2023 and is forecast to a readjusted size of US$ 14 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3U10467/Global_Zanamivir_Market_Insights_Forecast_to_2028
This report aims to provide a comprehensive presentation of the global market for Zanamivir, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Zanamivir by region & country, by Type, and by Application.
By Type
• Purity 97%
• Purity 98%
• Purity 99%
By Application
• Pharmaceutical
• Scientific Research
Key Companies
Merck, Tokyo Chemical Industry (TCI), DC Chemicals, Hairui Chemical, Key Organics, BioCrick, BLD Pharmatech, BOC Sciences, CSNpharm, Selleck Chemicals, Glentham Life Sciences
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-3U10467/global-zanamivir
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Zanamivir Market Size, Trends, Growth Analysis, and Forecast | Valuates Reports here
News-ID: 3825548 • Views: …
More Releases from Valuates Reports
Rice Husk-based Silica Market Size, Share & Forecast 2030 | Valuates Reports
Rice Husk-based Silica Market Size
The global Rice Husk-based Silica market was valued at US$ 481 million in 2023 and is anticipated to reach US$ 795.7 million by 2030, witnessing a CAGR of 7.3% during the forecast period 2024-2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-36J13108/Global_Rice_Husk_based_Silica_Market_Research_Report_2023
Rice Husk-based Silica Market Trends
Processing innovations refine the extraction process. Advanced calcination and acid leaching methods ensure minimal contamination, yielding silica suitable for high-
performance applications like silicone rubber and specialty…
Large Size Quartz Crucible (≥ 32 Inches) Market Surges as Solar Wafer Scaling …
Large Size Quartz Crucible (≥ 32 Inches) Market
The global Large Size Quartz Crucible (≥ 32 Inches) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-23C17402/Global_Large_Size_Quartz_Crucible_32_Inches_Market_Research_Report_2024
Get Free Sample:
By Type
• 32 Inches
• 36 Inches
By Application
• Semiconductor
• Photovoltaic
Key Companies
Shin-Etsu Quartz Products, Momentive Technologies, JSQ, Ferrotec, Dunyuanjuxin Semiconductor Technology, OJing Science and Technology, MeiJing Material (Zhejiang), Ningxia…
Quartz Crystal Microbalance (QCM) Biosensors Market Gains Momentum as Advanced R …
Quartz Crystal Microbalance (QCM) Biosensors Market
The global market for Quartz Crystal Microbalance (QCM) Biosensors was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-19O11267/Global_Quartz_Crystal_Microbalance_QCM_Biosensors_Market_Research_Report_2022
By Type
• Metal Sensors
• Oxide Sensors
• Carbide Sensors
• Polymer Sensors
By Application
• University
• Research institutions
• Life Science Company
Key Companies
Biolin Scientific (Addlife), AWSensors, Quartz Pro, INFICON, MicroVacuum, 3T analytik, Gamry Instruments, Shenzhen…
Quartz Glass for Semiconductor Market Expands as Advanced Chip Manufacturing Dri …
Quartz Glass for Semiconductor Market Size
The global market for Quartz Glass for Semiconductor was valued at US$ 2341 million in the year 2024 and is projected to reach a revised size of US$ 3048 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3K5456/Global_Quartz_Glass_for_Semiconductor_Market_Insights_Forecast_to_2028
By Type
• Fused Quartz
• Natural Quartz
• Synthetic Quartz
By Application
• Semiconductor Industry
Key Companies
Pacific Quartz, Heraeus, CoorsTek, Tosoh, AGC, Corning, Shin-Etsu Quartz Products Co., Ltd., Raesch Quarz…
More Releases for Zanamivir
Influenza Medication Market Size, Share, and Forecast 2023-2028 - by Types (Zana …
The Global Influenza Medication Market Report 2023 by 𝐏𝐫𝐚𝐠𝐦𝐚 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 provides a comprehensive overview of the market's latest trends, size, regulations, key players, and strategies. The report offers valuable insights into the market's sales and revenue, product type, applications, regions, and leading players.
It also covers key players and competitor analysis, providing a comprehensive understanding of the market's commercial landscape. The report is useful for gaining insights and understanding the…
Best Report on Influenza Medication Market with Segment (Zanamivir, Oseltamivir …
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter.…
Influenza Vaccine Market : New Study Offers Insights for 2019 | Zanamivir, Oselt …
Global Influenza Medication Market: Snapshot
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza…
Influenza Drugs and Vaccines Trends, Status, Sales, Revenue, Price and Gross Mar …
Global Influenza Drugs and Vaccines Market:
WiseGuyReports.com adds “Influenza Drugs and Vaccines Market 2017 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2022”reports to its database.
WiseGuyReports.Com Publish a New Market Research Report On –
Executive Summary:
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Influenza Market on the basis of Segment Type…
The Future Growth of Global Influenza Drugs and Vaccines Market - By Drugs (Zana …
"The Report Global Influenza Drugs and Vaccines Market - By Drugs (Zanamivir, Oseltamivir Phosphate, Peramivir), By Vaccine (Trivalent, Quadrivalent) - Analysis By Region, By Country: Opportunities and Forecast (2016-2021) - By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, China, India, Japan) provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
A comprehensive research report created through extensive…
Global Zanamivir Market 2016 - GlaxoSmithKline, Simcere, Lunan Pharmaceutical
Zanamivir is a neuraminidase inhibitor used in the treatment and prophylaxis of influenza caused by influenza A and B viruses. It was developed by the Australian biotech firm Biota Holdings. It was licensed to Glaxo in 1990 and approved in the US in 1999, only for use as a treatment for influenza. In 2006, it was approved for prevention of influenza A and B. Zanamivir was the first neuraminidase inhibitor…
